A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
Publication Date
11-15-2023
Content Type
Article
PubMed ID:
Citation
International Journal of Radiation Oncology, Biology, Physics (2023) 117(4):799-808